Rapid and substantive reductions in QOL functionality ( e.g. role functioning , 8-11 points at weeks 6 and 12 ) and symptom exacerbation ( e.g. fatigue , 4-8 points ; nausea and vomiting , 5 points , both at weeks 6 and 12 ) were observed in chemotherapy-treated patients .